Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed as a prospective, multi-centre, parallel group, double-blind
randomized, placebo-controlled, phase 3 clinical study to evaluate the efficacy and safety of
MP-513 (Teneligliptin).